Winton Group LTD Aim Immuno Tech Inc. Transaction History

Winton Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$0.67 - $1.18 $10,514 - $18,517	-15,693 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$0.92 - $1.96 $61,521 - $131,067	-66,871 Reduced 80.99%	15,693 $14,000
Q3 2021 Oct 28, 2021	BUY	$1.91 - $2.17 $52,849 - $60,043	27,670 Added 50.41%	82,564 $167,000
Q2 2021 Aug 10, 2021	BUY	$1.93 - $2.39 $105,945 - $131,196	54,894 New	54,894 $118,000

9.01M

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $11.1M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.